Enovis Corp Receivables Turnover Ratio (ENOV), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Enovis Corp  (NYSE: ENOV)
 

Enovis Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Enovis Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 5.21, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Enovis in Jul 03 2026 quarter, has decreased to 70 days, compared to 71 days, in the Apr 03 2026 quarter.

If we take a look into Healthcare sector 249 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jul 03 2026 from 1800 to 1943.

What is Receivable Turnover Ratio?
What is Enovis Corp Selling?


What is Receivable Turnover Ratio?





ENOV Receivables Turnover Ratio (Jul 03 2026)
II. Quarter
(Apr 03 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Oct 03 2025)
III. Quarter
(Jul 04 2025)
II. Quarter
Y / Y Receivable Change -2.61 % 1.97 % 8.78 % 7.88 % 14.94 %
Y / Y Revenue Change 3.39 % 5.42 % 2.64 % 8.61 % 7.39 %
Receivable Turnover Ratio (TTM) 5.21 5.14 5.09 5.16 5.16
ENOV's Total Ranking # 1943 # 1800 # 1516 # 1816 # 1193
Accounts Receivable average collection period days 70 71 72 71 71
Seq. Receivable Change -0.53 % 0.32 % 2.55 % -4.83 % 4.15 %
Seq. Revenue Change -0.97 % 2.21 % 5.08 % -2.8 % 0.98 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 108
Healthcare Sector # 250
Overall Market # 1943

Receivable Turnover Ratio Statistics
High Average Low
0.68 0.51 0.37
(Dec 31 2013)   (Jun 30 2023)






Financial Statements
Enovis's Accounts Receivable $ 442 Millions Visit ENOV's Balance sheet
Enovis's Sales TTM $ 2,295 Millions Visit ENOV's Income Statement
Sources of ENOV's Revenues Visit ENOV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ENOV's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ENOV's Growth Rates ENOV's Roa ENOV's Inventory Turnover Ratio ENOV's Dividend Comparisons
ENOV's Profitability Ratios ENOV's Roi ENOV's Asset Turnover Ratio ENOV's Dividend Growth
ENOV's Valuation Ratios ENOV's Roe ENOV's Financial Strength Ratios ENOV's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jul 03 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jul 03 2026 Receivable at quarter ending Jul 03 2026
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Talkspace Inc   14.09 $ 246.631  Millions$ 17.506  Millions
Lifestance Health Group Inc   14.07 $ 1,584.834  Millions$ 112.665  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Amneal Pharmaceuticals Inc   13.83 $ 3,117.474  Millions$ 225.492  Millions
Arvinas Inc   13.49 $ 316.700  Millions$ 23.475  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Corcept Therapeutics Inc  13.30 $ 830.813  Millions$ 62.477  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Skinhealth Systems Inc   13.04 $ 289.224  Millions$ 22.179  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Irhythm Holdings Inc   10.32 $ 825.702  Millions$ 80.007  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions

Date modified: 2026-09-08T17:33:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.